This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Progress toward the clinical application of autologous induced pluripotent stem cells and gene repair therapy for treatm

April 1st, 2011

Study shows, for the first time, the successful reprogramming of diseased human hepatocytes into induced pluripotent stem cells (iPSC).

Results also found differentiation into mature hepatocytes was more efficient than that with fibroblast-derived iPSCs.

The generation of diseased hepatocyte-derived human iPSC lines provides a good basis for the study of liver disease pathogenesis.

Such technology could give a potentially unlimited reservoir of cells for the treatment of human liver diseases: generating genetically corrected liver cells via auto-transplantation of genetically modified hepatocytes, thus avoiding liver transplant and lifelong immunosuppression.

More information:
Bosman, A. et al. Progress toward the clinical application of autologus induced pluripotent stem cells and gene repair therapy for treatment of familial hypercholesterolemia. Abstract presented at The International Liver CongressTM 2011. www1.easl.eu/easl2011/program/Orals/187.htm

Provided by European Association for the Study of the Liver

Citation: Progress toward the clinical application of autologous induced pluripotent stem cells and gene repair therapy for treatm (2011, April 1) retrieved 14 August 2026 from https://sciencex.com/wire-news/63086997/progress-toward-the-clinical-application-of-autologous-induced-p.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.